Literature DB >> 16366605

Methyl substitution on the piperidine ring of N-[omega-(6-methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the sigma(1) receptor.

Francesco Berardi1, Savina Ferorelli, Carmen Abate, Maria P Pedone, Nicola A Colabufo, Marialessandra Contino, Roberto Perrone.   

Abstract

The N-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl and N-(6-methoxynaphthalen-1-yl)propyl derivatives as well as their upper homologous butyl derivatives of various methylpiperidines were prepared. The piperidine moiety bearing monomethyl or geminal dimethyl groups was employed as a probe to explore sigma-subtype affinities and selectivities by radioligand binding assays at sigma(1) and sigma(2) receptors and the Delta(8)-Delta(7) sterol isomerase (SI) site. 4-Methyl derivative 31 was the most potent sigma(1) ligand (K(i)=0.030 nM) with a good selectivity profile (597-fold and 268-fold relative to sigma(2) receptor and SI site, respectively), whereas 3,3-dimethyl derivative 26 (K(i)=0.35 nM) was the most selective (680-fold) relative to the sigma(2) receptor. Both compounds can be proposed as tools for PET experiments. Furthermore, the naphthalene compounds 26, 28, 31, and 33 demonstrated antiproliferative activity in rat C6 glioma cells (EC(50) = 15.0 microM for 33), revealing a putative sigma(1) antagonist activity and opening a useful perspective in tumor research and therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16366605     DOI: 10.1021/jm050654o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors.

Authors:  Carmen Abate; Chiara Riganti; Maria Laura Pati; Dario Ghigo; Francesco Berardi; Timur Mavlyutov; Lian-Wang Guo; Arnold Ruoho
Journal:  Eur J Med Chem       Date:  2015-12-13       Impact factor: 6.514

2.  Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors.

Authors:  Maria Laura Pati; Mauro Niso; Dirk Spitzer; Francesco Berardi; Marialessandra Contino; Chiara Riganti; William G Hawkins; Carmen Abate
Journal:  Eur J Med Chem       Date:  2017-12-08       Impact factor: 6.514

3.  Synthesis, radiolabelling, and evaluation of [11C]PB212 as a radioligand for imaging sigma-1 receptors using PET.

Authors:  Francesco Spinelli; Ahmed Haider; Annamaria Toscano; Maria Laura Pati; Claudia Keller; Francesco Berardi; Nicola Antonio Colabufo; Carmen Abate; Simon M Ametamey
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

4.  New positron emission tomography (PET) radioligand for imaging σ-1 receptors in living subjects.

Authors:  Michelle L James; Bin Shen; Cristina L Zavaleta; Carsten H Nielsen; Christophe Mesangeau; Pradeep K Vuppala; Carmel Chan; Bonnie A Avery; James A Fishback; Rae R Matsumoto; Sanjiv S Gambhir; Christopher R McCurdy; Frederick T Chin
Journal:  J Med Chem       Date:  2012-09-20       Impact factor: 7.446

Review 5.  Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives.

Authors:  Francesca Serena Abatematteo; Mauro Niso; Marialessandra Contino; Marcello Leopoldo; Carmen Abate
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

Review 6.  PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti-SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships.

Authors:  Carmen Abate; Mauro Niso; Francesca Serena Abatematteo; Marialessandra Contino; Nicola Antonio Colabufo; Francesco Berardi
Journal:  Front Pharmacol       Date:  2020-12-07       Impact factor: 5.810

Review 7.  Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.

Authors:  Kinga Sałaciak; Karolina Pytka
Journal:  Neurosci Biobehav Rev       Date:  2021-11-01       Impact factor: 8.989

Review 8.  Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022.

Authors:  Paweł Kozyra; Monika Pitucha
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

9.  QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs.

Authors:  Yangxi Yu; Hiep Dong; Youyi Peng; William J Welsh
Journal:  Molecules       Date:  2021-08-30       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.